Cargando…
A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593167/ https://www.ncbi.nlm.nih.gov/pubmed/35871588 http://dx.doi.org/10.2169/internalmedicine.0319-22 |
| _version_ | 1784815099530182656 |
|---|---|
| author | Yamada, Shunsuke Yamada, Kanako Nishida, Hiroshi |
| author_facet | Yamada, Shunsuke Yamada, Kanako Nishida, Hiroshi |
| author_sort | Yamada, Shunsuke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9593167 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Japanese Society of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95931672022-11-07 A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine Yamada, Shunsuke Yamada, Kanako Nishida, Hiroshi Intern Med Letters to the Editor The Japanese Society of Internal Medicine 2022-07-22 2022-10-01 /pmc/articles/PMC9593167/ /pubmed/35871588 http://dx.doi.org/10.2169/internalmedicine.0319-22 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letters to the Editor Yamada, Shunsuke Yamada, Kanako Nishida, Hiroshi A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title | A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title_full | A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title_fullStr | A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title_full_unstemmed | A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title_short | A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine |
| title_sort | case of sequential development of polymyalgia rheumatica and guillain-barré syndrome following administration of the pfizer-biontech covid-19 vaccine |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593167/ https://www.ncbi.nlm.nih.gov/pubmed/35871588 http://dx.doi.org/10.2169/internalmedicine.0319-22 |
| work_keys_str_mv | AT yamadashunsuke acaseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine AT yamadakanako acaseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine AT nishidahiroshi acaseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine AT yamadashunsuke caseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine AT yamadakanako caseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine AT nishidahiroshi caseofsequentialdevelopmentofpolymyalgiarheumaticaandguillainbarresyndromefollowingadministrationofthepfizerbiontechcovid19vaccine |